Inventor · disambiguated record
William Kubasek
Also filed as: KUBASEK WILLIAM
4 granted patents·8 pending applications·244 citations·filing 1996–2017
78Inventor score
Files withMERRIMACK PHARMACEUTICALS INC6GARCIA GABRIELA2KUBASEK WILLIAM1ONSUM MATTHEW DAVID1PRAECIS PHARM INC1
Top patents by PatentIndex Score
12 records- 0196US5854204AAβ peptides that modulate β-amyloid aggregationPRAECIS PHARM INC·Filed 1996·Granted Dec 29, 1998·230 cites·10 claims
- 0287US8623592B2Methods and systems for predicting response of cells to a therapeutic agentSCHOEBERL BIRGIT·Filed 2009·Granted Jan 7, 2014·9 cites·11 claims
- 0384US9688761B2Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·4 cites·24 claims
- 0474US10273304B2Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·1 cites·36 claims
- 0567US2014127238A1Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted responseMERRIMACK PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0658US2017307631A1Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted responseMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0757US2011027291A1Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted responseMERRIMACK PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0855US2017210810A1Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0941US2014248280A1Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancersKUBASEK WILLIAM·Filed 2012·Application pending·0 cites
- 1039US2014234317A1Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agentsONSUM MATTHEW DAVID·Filed 2012·Application pending·0 cites
- 1138US2015231238A1Overcoming resistance to erbb pathway inhibitorsGARCIA GABRIELA·Filed 2012·Application pending·0 cites
- 1232US2014134170A1Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancersGARCIA GABRIELA·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →